Discontinued — last reported Q4 '25
Labcorp Holdings Share Buybacks decreased by 56.4% to $98.00M in Q1 2026 compared to the prior quarter. Over 2 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -48.1% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $300.00M | $300.00M | $1.00B | $0.00 | $400.00M | $800.00M | $300.00M | $1.01B | $75.00M | $75.10M | $0.00 | $200.00M | $25.00M | $225.00M | $98.00M |
| QoQ Change | — | +0.0% | +233.3% | -100.0% | — | +100.0% | -62.5% | +236.3% | -92.6% | +0.1% | -100.0% | — | -87.5% | +800.0% | -56.4% |
| YoY Change | — | — | — | — | +33.3% | +166.7% | -70.0% | +26.1% | -92.6% | — | — | — | -66.7% | +199.6% | — |